Vietnam Pharmaceutical Comprehensive Report Q1/2020
VIETNAM PHARMACEUTICAL INDUSTRY
The pharmaceutical industry of Vietnam uses about xx tons of pharmaceutical materials, of which about xx-xx% of used pharmaceutical materials with imported origin.In 2019, Vietnam imported USD xx million of pharmaceutical raw materials, reducing x % compared to the same period in 2018.
By the end of 2018, there were xx enterprises operating in the manufacturing, pharmaco-chemical and pharmaceutical industries. The total market value of the pharmaceutical industry in 2019 is estimated at x million USD, the proportion of which is mainly from imported pharmaceuticals. Although per capita consumption of Vietnam is growing with CAGR (2012 - 2019) reaching x%. In 2019, pharmaceutical exports are estimated to increase by x% compared to 2018, reaching USD xx million,
The pharmaceutical industry of Vietnam uses about xx tons of pharmaceutical materials, of which about xx-xx% of used pharmaceutical materials with imported origin.In 2019, Vietnam imported USD xx million of pharmaceutical raw materials, reducing x % compared to the same period in 2018.
By the end of 2018, there were xx enterprises operating in the manufacturing, pharmaco-chemical and pharmaceutical industries. The total market value of the pharmaceutical industry in 2019 is estimated at x million USD, the proportion of which is mainly from imported pharmaceuticals. Although per capita consumption of Vietnam is growing with CAGR (2012 - 2019) reaching x%. In 2019, pharmaceutical exports are estimated to increase by x% compared to 2018, reaching USD xx million,
Abbreviations
Report summary
1. BUSINESS ENVIRONMENT
1.1. Macroeconomic situation
1.2. Legal framework
1.3. Trade Agreements
2. PHARMACEUTICAL INDUSTRY OVERVIEW
2.1. Global Pharmaceutical Industry
2.1.1. Production - Consumption
2.1.2. Export - Import
2.1.3. Production and Consumption Situation in major countries
2.1.4. Large Enterprises in the world
2.2. Vietnam Pharmaceutical Industry Overview
2.2.1. History of Vietnam Pharmaceutical Industry
2.2.2. Industry Position
2.2.3. Industry Scale and Feature
2.2.4. Value Chain of Vietnam Pharmaceutical Industry
2.2.5. Raw materials
2.2.6. Production technology
2.2.7. R&D
2.2.8. Production
2.2.9. Consumption
2.2.10. Export - Import
2.2.11. Price movements
2.2.12. Distribution system
2.3. Risks and challenges
2.4. Industry planning
2.5. Driving forces and forecast
3. ENTERPRISE ANALYSIS
3.1. Profitability Ratios
3.2. Cost structure
3.3. Asset Management Ratios
3.4. Capital Structure
3.5. Solvency
3.6. Return on Investment
4. APPENDIX OF FINANCIAL STATEMENTS
Report summary
1. BUSINESS ENVIRONMENT
1.1. Macroeconomic situation
1.2. Legal framework
1.3. Trade Agreements
2. PHARMACEUTICAL INDUSTRY OVERVIEW
2.1. Global Pharmaceutical Industry
2.1.1. Production - Consumption
2.1.2. Export - Import
2.1.3. Production and Consumption Situation in major countries
2.1.4. Large Enterprises in the world
2.2. Vietnam Pharmaceutical Industry Overview
2.2.1. History of Vietnam Pharmaceutical Industry
2.2.2. Industry Position
2.2.3. Industry Scale and Feature
2.2.4. Value Chain of Vietnam Pharmaceutical Industry
2.2.5. Raw materials
2.2.6. Production technology
2.2.7. R&D
2.2.8. Production
2.2.9. Consumption
2.2.10. Export - Import
2.2.11. Price movements
2.2.12. Distribution system
2.3. Risks and challenges
2.4. Industry planning
2.5. Driving forces and forecast
3. ENTERPRISE ANALYSIS
3.1. Profitability Ratios
3.2. Cost structure
3.3. Asset Management Ratios
3.4. Capital Structure
3.5. Solvency
3.6. Return on Investment
4. APPENDIX OF FINANCIAL STATEMENTS
LIST OF FIGURES
Figure 1: Share of healthy sector and social assistance activities in total GDP, 2010-2019
Figure 2: Consumer price index of drug and medical service, 2012 - 2019
Figure 3: Population and population growth, 2010 - 2019
Figure 4: VND/USD exchange rate, 1/2013 - 12/2019
Figure 5: VND/CNY exchange rate, 1/2016 – 12/2019
Figure 6: Import of pharmaceutical products, 2012-2019e
Figure 7: Quantity of new drugs licensed by FDA, 2010 - 2019
Figure 8: World E&D investment costs, 2010-2024f
Figure 9: Top 10 enterprises with the largest R&D costs, 2018
Figure 10: Top 10 enterprises with the largest R&D costs, 2024
Figure 11: Revenue of the global pharmaceutical industry, 2010 - 2019e
Figure 12: Degree of risk from loss of patent protection, 2012-2019e
Figure 14: World sales of prescription and generic drug, 2010-2019e
Figure 13: Share of pharmaceutical sales by technology, 2010-2019e
Figure 15: Pharmaceutical consumption market share by group, 2018
Figure 16: Spending on medicines by treatment area, 2018
Figure 17: Net revenue of manufactures per capita, 2014-2019e
Figure 18: Growth of Chinese pharmaceutical revenue, 2012-2018
Figure 19: Top 10 world pharmaceutical enterprises by revenue and R&D costs, 2019
Figure 20: Import of raw materials, 2013 - 2019e
Figure 22: Import of pharmaceutical raw materials, 2018 - 2019e
Figure 23: Average capital, fixed assets and long-term average investment of enterprises, 2010 - 2018
Figure 24: Number of enterprises and workers in medicine, chemical and pharmaceutical manufacturing sectors, 2010 - 2018
Figure 25: Net Revenue and profit before tax, 2010 - 2018
Figure 26: Domestic pharmaceutical production value, 2010 - 2019e
Figure 27: The market value of pharmaceutical industry, 2013 - 2019e
Figure 28: Value ratio of domestically produced medicines in Vietnam, 2010 – 2019e
Figure 29: Domestically produced medicine consumption, 2010 – 2019e
Figure 30: Spending on medicines in Vietnam, 2009 – 2019e
Figure 31: Spending on medicines per capita in some countries, 2018e
Figure 32: Structure of drug consumption by channel, 2013- 2019e
Figure 33: Situation of patented and generic drugs, 2013-2019e
Figure 34: Market value of prescription drugs (ETC), 2011 – 2019e
Figure 35: Over-the-counter (OTC) market, 2013 - 2019e
Figure 36: OTC market share by sales channel, 2019e
Figure 37: Patented drugs (Patent), 2010 – 2019e
Figure 38: Generic drug market, 2013 – 2019e
Figure 39: Import of pharmaceutical products from a number of countries, 2018 - 2019e
Figure 41: Import of pharmaceutical products from India, 2013 – 2019e
Figure 42: Pharmaceutical exports, 2012-2019e
Figure 43: Top major exporting countries, 2019
Figure 44: Drug declared and re-declared prices (increased), 2013-2018
Figure 46: Top distribution companies by revenue, 2018e
Figure 47: Sales of typical distribution chains, 2017-2018
Figure 48: The rate of unsatisfactory sample, 2010-2018
Figure 49: M&A of pharmaceutical industry, 2010-2019
Figure 50: Sales of prescription drug, 2017-2024f
Figure 51: Prescription drug sales of the top 10 largest companies, 2024f
Figure 52: Drug manufacturing by technology,2017-2024f
Figure 53: Growth of total drug consumption value in Vietnam, 2013-2013f
Figure 54: Median drug spending per capita, 2017-2023f
Figure 55: DHG shareholder structure, 2018
Figure 56: TRA shareholder structure, 2018
Figure 57: DMC shareholder structure, 2018
Figure 58: Imexpharm shareholder structure, 2018
Figure 59: OPC shareholder structure, 2018
Figure 60: SPM shareholder structure, 2018
Figure 61: Vimedimex shareholder structure, 2018
Figure 62: DHT shareholder structure, 2018
Figure 63: DBT shareholder structure, 2018
Figure 64: LDP shareholder structure, 2018
Figure 65: Gross profit margin, 2017 - 2018
Figure 66: Selling expenses, 2017-2018
Figure 67: General and administration expenses, 2017-2018
Figure 68: Number of inventory days, 2018
Figure 72: Average payment period, 2018
Figure 73: Payment index, 2017-2018
Figure 74: Profit ratio, 2017 - 2018
Figure 1: Share of healthy sector and social assistance activities in total GDP, 2010-2019
Figure 2: Consumer price index of drug and medical service, 2012 - 2019
Figure 3: Population and population growth, 2010 - 2019
Figure 4: VND/USD exchange rate, 1/2013 - 12/2019
Figure 5: VND/CNY exchange rate, 1/2016 – 12/2019
Figure 6: Import of pharmaceutical products, 2012-2019e
Figure 7: Quantity of new drugs licensed by FDA, 2010 - 2019
Figure 8: World E&D investment costs, 2010-2024f
Figure 9: Top 10 enterprises with the largest R&D costs, 2018
Figure 10: Top 10 enterprises with the largest R&D costs, 2024
Figure 11: Revenue of the global pharmaceutical industry, 2010 - 2019e
Figure 12: Degree of risk from loss of patent protection, 2012-2019e
Figure 14: World sales of prescription and generic drug, 2010-2019e
Figure 13: Share of pharmaceutical sales by technology, 2010-2019e
Figure 15: Pharmaceutical consumption market share by group, 2018
Figure 16: Spending on medicines by treatment area, 2018
Figure 17: Net revenue of manufactures per capita, 2014-2019e
Figure 18: Growth of Chinese pharmaceutical revenue, 2012-2018
Figure 19: Top 10 world pharmaceutical enterprises by revenue and R&D costs, 2019
Figure 20: Import of raw materials, 2013 - 2019e
Figure 22: Import of pharmaceutical raw materials, 2018 - 2019e
Figure 23: Average capital, fixed assets and long-term average investment of enterprises, 2010 - 2018
Figure 24: Number of enterprises and workers in medicine, chemical and pharmaceutical manufacturing sectors, 2010 - 2018
Figure 25: Net Revenue and profit before tax, 2010 - 2018
Figure 26: Domestic pharmaceutical production value, 2010 - 2019e
Figure 27: The market value of pharmaceutical industry, 2013 - 2019e
Figure 28: Value ratio of domestically produced medicines in Vietnam, 2010 – 2019e
Figure 29: Domestically produced medicine consumption, 2010 – 2019e
Figure 30: Spending on medicines in Vietnam, 2009 – 2019e
Figure 31: Spending on medicines per capita in some countries, 2018e
Figure 32: Structure of drug consumption by channel, 2013- 2019e
Figure 33: Situation of patented and generic drugs, 2013-2019e
Figure 34: Market value of prescription drugs (ETC), 2011 – 2019e
Figure 35: Over-the-counter (OTC) market, 2013 - 2019e
Figure 36: OTC market share by sales channel, 2019e
Figure 37: Patented drugs (Patent), 2010 – 2019e
Figure 38: Generic drug market, 2013 – 2019e
Figure 39: Import of pharmaceutical products from a number of countries, 2018 - 2019e
Figure 41: Import of pharmaceutical products from India, 2013 – 2019e
Figure 42: Pharmaceutical exports, 2012-2019e
Figure 43: Top major exporting countries, 2019
Figure 44: Drug declared and re-declared prices (increased), 2013-2018
Figure 46: Top distribution companies by revenue, 2018e
Figure 47: Sales of typical distribution chains, 2017-2018
Figure 48: The rate of unsatisfactory sample, 2010-2018
Figure 49: M&A of pharmaceutical industry, 2010-2019
Figure 50: Sales of prescription drug, 2017-2024f
Figure 51: Prescription drug sales of the top 10 largest companies, 2024f
Figure 52: Drug manufacturing by technology,2017-2024f
Figure 53: Growth of total drug consumption value in Vietnam, 2013-2013f
Figure 54: Median drug spending per capita, 2017-2023f
Figure 55: DHG shareholder structure, 2018
Figure 56: TRA shareholder structure, 2018
Figure 57: DMC shareholder structure, 2018
Figure 58: Imexpharm shareholder structure, 2018
Figure 59: OPC shareholder structure, 2018
Figure 60: SPM shareholder structure, 2018
Figure 61: Vimedimex shareholder structure, 2018
Figure 62: DHT shareholder structure, 2018
Figure 63: DBT shareholder structure, 2018
Figure 64: LDP shareholder structure, 2018
Figure 65: Gross profit margin, 2017 - 2018
Figure 66: Selling expenses, 2017-2018
Figure 67: General and administration expenses, 2017-2018
Figure 68: Number of inventory days, 2018
Figure 72: Average payment period, 2018
Figure 73: Payment index, 2017-2018
Figure 74: Profit ratio, 2017 - 2018
LIST OF TABLES
Table 1: Drug exporting countries, 2016-2018
Table 2: Countries importing drugs, 2016-2018
Table 3: General information about the US health sector, 2018e
Table 4: General information about the Japanese health sector, 2018e
Table 5: General information about the German health sector, 2018e
Table 6: Some main machines and equipment in the Pharmaceutical production line
Table 7 Origin of machinery and equipment of some big pharmaceutical
production companies
Table 8: Average R&D cost for new drug production
Table 9 Statistics of drug production by categories, 2013 - 2019e
Table 10: M&A of pharmaceutical manufacturing group, 2016 - 2019
Table 11:Top import partners of Vietnam, 2019
Table 12: Top pharmaceutical importing enterprises, 2019
Table 13: Top exporters, 2019
Table 14: Statistics of differences in selling prices of some drugs at pharmacies, 2019
Table 15: Number of health facilities, 2012 - 2017
Table 16: Typical drugstore chains, 2019
Table 17: M&A of pharmaceutical distribution group, 2017 - 2018
Table 18: Top 15 M&A in the world, 2019
Table 19: Top technology enterprises in Biotechnology, 2024
Table 20: 10 typical pharmaceutical enterprises in 2018
Table 1: Drug exporting countries, 2016-2018
Table 2: Countries importing drugs, 2016-2018
Table 3: General information about the US health sector, 2018e
Table 4: General information about the Japanese health sector, 2018e
Table 5: General information about the German health sector, 2018e
Table 6: Some main machines and equipment in the Pharmaceutical production line
Table 7 Origin of machinery and equipment of some big pharmaceutical
production companies
Table 8: Average R&D cost for new drug production
Table 9 Statistics of drug production by categories, 2013 - 2019e
Table 10: M&A of pharmaceutical manufacturing group, 2016 - 2019
Table 11:Top import partners of Vietnam, 2019
Table 12: Top pharmaceutical importing enterprises, 2019
Table 13: Top exporters, 2019
Table 14: Statistics of differences in selling prices of some drugs at pharmacies, 2019
Table 15: Number of health facilities, 2012 - 2017
Table 16: Typical drugstore chains, 2019
Table 17: M&A of pharmaceutical distribution group, 2017 - 2018
Table 18: Top 15 M&A in the world, 2019
Table 19: Top technology enterprises in Biotechnology, 2024
Table 20: 10 typical pharmaceutical enterprises in 2018
